Abstract
The primary objective of the present study was to compare the rates of plasma clearance and hepatic utilization of stearic (18∶0), myristic (14∶0) and linoleic (18∶2) acids, as introducedvia chylomicrons. Lymph chylomicrons were specifically labeledin vivo with [14C]stearic and (SA), [14C]myristic acid (MA), or [14C]linoleic acid (LA) by infusing donor rats intraduodenally with the labeled fatty acids in a lipid emulsion. Following intravenous injection of recipient rats with the labeled chylomicrons, the rates of plasma clearance and incorporation of the label in triglycerides (TG), phospholipids (PL) and other lipids in the liver were compared at 5, 15 and 30 min. [14C]SA was cleared at a slightly faster rate (t1/2=7.0 min) than [14C]MA (t1/2=8.1 min) and [14C]LA (t1/2=8.0 min) (P<0.05). [14C]SA was accumulated in the liver at a significantly faster rate than [14C]MA and [14C]LA. At the peak (15 min) of hepatic uptake, 30.3% of [14C]SA, 26.2% of [14C]LA and 21.9% of [14C]MA were recovered in the liver. At 30 min, 33.5% of [14C]SA was taken up by the liver, whereas 27.8% of [14C]LA and only 15.2% of [14C]MA were removed. In the liver, the percentage of [14C]SA incorporated into PL steadily increased with time, whereas the percent-age incorporated into TG decreased. [14C]SA was preferentially incorporated into PL at all time intervals, as compared with [14C]MA and [14C]LA. At 30 min, 38.6% of [14C]SA was found in PL, and only 5.2% of [14C]MA and 12.0% of [14C]LA were present in PL. A large proportion of hepatic [14C]MA remained unesterified (free fatty acid) throughout the 30-min period, with a small proportion incorporated into PL and TG. Of the total liver14C radioactivity recovered at 30 min, 63.8% of [14C]MA, 48.8% of [14C]LA and 25.5% of [14C]SA were found unesterified. During 30 min, a significantly greater amount of [14C]MA (76.9%) was oxidized in both the liver and the peripheral tissue combined, compared with [14C]LA (64.7%) and [14C]SA (61.2%). A higher proportion of [14C]LA was incorporated into TG than into PL at all time intervals. No differences were noted in the relative distribution of14C in cholesterol and other lipids among the three fatty acids. Using labeled fatty acids incorporatedin vivo into chylomicrons, the present study demonstrated that SA, MA and LA are distinctly different in their metabolic behavior. During the initial 30 min after their entry into the blood, 92–95% of the fatty acids were cleared. During this early phase of metabolism, [14C]SA was preferentially utilized for liver PL synthesis, whereas [14C]LA was better incorporated into TG. [14C]MA was poorly incorporated into hepatic lipids, but was preferentially oxidized in the liver or utilized by the peripheral tissue.
Similar content being viewed by others
Abbreviations
- FFA:
-
free fatty acid
- LA:
-
linoleic acid
- LDL:
-
low-density lipoprotein(s)
- LPL:
-
lipoprotein lipase
- MA:
-
myristic acid
- OA:
-
oleic acid
- PA:
-
palmitic acid
- PL:
-
phospholipid
- SA:
-
stearic acid
- TLC:
-
thin-layer chromatography
- TG:
-
triglyceride
- VLDL:
-
very low density lipoproteins
References
Kritchevsky, D. (1988)Nutr. Rev. 46, 177–181.
Chen, I.S., Subramaniam, S., Vahouny, G.V., Cassidy, M.M., Ikeda, I., and Kritchevsky, D. (1989)J. Nutr. 119, 1569–1573.
Bergstedt, S.E., Hayashi, H., Kritchevsky, D., and Tso, P. (1990)Am. J. Physiol. 259, G386-G396.
Bonanome, A., and Grundy, S.M. (1988)N. Engl. J. Med. 318, 1244–1248.
Bonanome, A., and Grundy, S.M. (1989)J. Nutr. 119, 1556–1560.
Denke, M.A., and Grundy, S.M. (1991)Am. J. Clin. Nutr. 54, 1036–1040.
Wang, S., and Koo, S.I. (1992)FASEB J. 6, A1384.
Leyton, J., Drury, P.J., and Crawford, M.A. (1987)Lipids 22, 553–557.
American Institute of Nutrition (1977)J. Nutr. 107, 1340–1348.
American Institute of Nutrition (1980)J. Nutr. 110, 1726.
Koo, S.I., Henderson, D.A., Algilani, K., and Norvell, J.E. (1985)Am. J. Clin. Nutr. 42, 671–680.
Koo, S.I., Algilani, K., Norvell, J.E., and Henderson, D.A. (1986)Am. J. Clin. Nutr. 43, 429–437.
Baker, R.D., Guillet, G.G., and Maynes, C.C. (1962)J. Appl. Physiol. 17, 1020–1021.
Clark, S.B., Atkinson, D., Hamilton, J.A., Forte, T., Russel, B., Feldman, E.B., and Small, D.M. (1982)J. Lipid Res. 23, 28–41.
Riley, V. (1960)Proc. Soc. Exp. Biol. Med. 104, 751–754.
Koo, S.I., Lee, C.L., Stone, W.I., and Scott, R.L. (1992)J. Nutr. Biochem. 3, 45–51.
Folch, J., Lees, M., and Stanley, G.H.S. (1957)J. Biol. Chem. 226, 497–509.
Slaver, H.T., and Lanza, E. (1979)J. Am. Oil Chem. Soc. 56, 933–943.
Nestel, P.J., and Barter, P. (1971)Clin. Sci. 40, 345–350.
Nicolosi, R.J., and Stucchi, A.F. (1990)Arteriosclerosis 10, 119–128.
Benner, K.G., Sasaki, A., Gowen, D.R., Weaver, A., and Conner, W.E. (1990)Lipids 25, 534–540.
Green, P.H.R., and Glickman, R.M. (1981)J. Lipid Res. 22, 1153–1173.
Sherill, B.C., Innerarity, T.L., and Mahley, R.W. (1980)J. Biol. Chem. 225, 1804–1807.
Elovson, J. (1965)Biochim. Biophys. Acta 106, 480–494.
Keys, A., Anderson, J.T., and Grande, F. (1965)Metabolism 14, 776–787.
Hegsted, D.M., McGandy, R.B., Myers, M.L., and Stare, F.J. (1965)Am. J. Clin. Nutr. 17, 281–295.
Feldman, E.B., Russell, B.S., Schnare, F.H., Moretti-Rojas, I., Miles, B.C., and Doyle, E.A. (1979)J. Nutr. 109, 2237–2246.
Ohtani, H., Hayashi, K., Hirata, Y., Dojo, S., Nakashima, K., Nishio, E., Kurushima, H., Saeki, M., and Kajiyama, G. (1990)J. Lipid Res. 31, 1413–1422.
Wilcox, H.G., Dunn, G.D., and Heimberg, M. (1975)Biochim. Biophys. Acta 398, 39–54.
Mattson, F.H., and Grundy, S.M. (1985)J. Lipid Res. 26, 194–202.
Bagdade, J.D., Hazzard, W.R., and Carlin, J. (1970)Metabolism 19, 1020–1024.
Shepherd, J., Packard, C.J., Grundy, S.M., Yeshurum, D., Gotto, A.M., and Taunton, O.D. (1980)J. Lipid Res. 21, 91–99.
Kovanen, P.T., Brown, M.S., Basu, S.K., Bilheimer, D.W., and Goldstein, J.L. (1981)Proc. Natl Acad. Sci. USA 78, 1396–1400.
Spady, D.K., and Dietschy, J.M. (1988)J. Clin. Invest. 81, 300–309.
Loscalzo, J.L., Freedman, J., Rudd, M.A., Vasserman-Barsky, I., and Vaughan, D.E. (1987)Arteriosclerosis 7, 450–455.
Author information
Authors and Affiliations
About this article
Cite this article
Wang, S., Koo, S.I. Plasma clerance and hepatic utilization of stearic, myristic and linoleic acids introducedvia chylomicrons in rats. Lipids 28, 697–703 (1993). https://doi.org/10.1007/BF02535989
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02535989